cryptate

cryptate

[′krip‚tāt]
(inorganic chemistry)
The adduct formed between a cryptand and a guest (cation, anion, or neutral species) molecular entity.
References in periodicals archive ?
This assay has the advantage of using time-resolved amplified cryptate emission technology and is based on polyclonal anti-CT and monoclonal anti-catacalcin antibodies that bind CT and its precursor molecules.
[9] also studied the structure and emission spectrum of the europium cryptate containing 3,3-biisoquinoline-2,2-dioxide with the framework of the Sparkle/AM1 model and Judd--Ofelt theory.
Lu, "CO2 fixation and transformation by a dinuclear copper cryptate under acidic conditions," Chemistry-An Asian Journal, vol.
S100B serum levels were assessed using electrochemiluminescence immunoassay (ECLIA; Cobase 411); PCT serum levels were measured using the TRACE-Technology (Time-resolved Amplified Cryptate Emission; Kryptor).
Procalcitonin was measured by BRAHMS Kryptor compact assay (Henningsdorf, Germany), the most sensitive and highly precise plasma PCT measurement using time-resolved amplified cryptate emission (TRACE) technology assay with the quantitative result in 19 minutes.
The covalent antibody-fluorophore conjugates were made at Perkin-Elmer, including TSD-Europium cryptate (TSD-Eu), 565-Europium cryptate (565-Eu), and 26D6-allophycocyanin (26D6-APC).
This assay is based on the competition between the sample free cortisol and XL665 labelled cortisol for binding to an anticortisol europium cryptate labelled antibody.
We measured the concentrations of PAPP-A and hCG[beta] by use of a homogeneous random-access semi-automated assay, employing time-resolved amplified cryptate emission (TRACE) technology using the Kryptor instrument (Brahms AG).
Anion receptor molecules: synthesis of an octaaza-cryptand and structure of its fluoride cryptate. Tetrahedron Lett.
Lu, "C[O.sub.2] fixation and transformation by a dinuclear copper cryptate under acidic conditions," Chemistry--An Asian Journal, vol.
We used time-resolved amplified cryptate emission (TRACE) technology in a Kryptor[R] autoanalyzer (BRAHMS) to measure plasma procalcitonin (PCT) concentrations in patients who developed an infection or AR on the day of the clinical diagnosis of these complications.